Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.
Elevance Health's Capital Expenditure for the
three
months ended in Mar. 2024 was $-279.00 Mil. Its Revenue for the
three
months ended in Mar. 2024 was $42,577.00 Mil.
Hence, Elevance Health's Capex-to-Revenue for the
three
months ended in Mar. 2024 was 0.01.
Elevance Health Capex-to-Revenue Historical Data
The historical data trend for Elevance Health's Capex-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Elevance Health's Capex-to-Revenue
For the Healthcare Plans subindustry, Elevance Health's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elevance Health's Capex-to-Revenue Distribution in the Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Elevance Health's Capex-to-Revenue distribution charts can be found below:
* The bar in red indicates where Elevance Health's Capex-to-Revenue falls into.
Elevance Health Capex-to-Revenue Calculation
Elevance Health's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elevance Health (NYSE:ELV) Capex-to-Revenue Explanation
Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.
Elevance Health Capex-to-Revenue Related Terms
Thank you for viewing the detailed overview of Elevance Health's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Elevance Health (Elevance Health) Business Description
Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 48 million medical members as of June 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ELV has been successfully added to your 